Last updated: September 21, 2022
Sponsor: jiaoliqun
Overall Status: Active - Recruiting
Phase
N/A
Condition
Atherosclerosis
Blood Clots
Cerebral Ischemia
Treatment
N/AClinical Study ID
NCT05550077
OCT-ICAS
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Symptomatic ICAS. Participants with ICAS with a transient ischaemic attack (TIA) orstroke attributable to the territory of the stenotic artery were defined assymptomatic. A TIA was defined as a transient episode of neurological dysfunction (focal weakness or language disturbance, transient monocular blindness, or requiredassistance in walking) caused by focal brain or retinal ischaemia that lasted for atleast 10 minutes but resolved within 24 hours
- Stenotic degree ≥ 50%, measured by digital subtraction angiography
- The stenosis must located in at least one major intracranial artery (internal carotidartery, vertebral artery, middle cerebral artery, or basilar artery)
Exclusion
Exclusion Criteria:
- Arteriovenous Malformation
- Aneurysm
Study Design
Total Participants: 400
Study Start date:
March 15, 2020
Estimated Completion Date:
December 31, 2027
Study Description
Connect with a study center
Xuanwu Hospital, Capital Medical University
Beijing, Beijing 100005
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.